A public hearing on potential drug therapies to help addicted young people quit electronic cigarettes has been rescheduled, according to the US Food and Drug Administration, which issued a note through its Center for Tobacco Products.
The FDA said it had posted a notice in the Federal Register rescheduling the public hearing to January 18, at the FDA White Oak campus in Silver Spring, Maryland.
‘Individuals interested in presenting at the hearing must register by January 8, 2019,’ the note said.
‘Those interested in attending the hearing in person or watching the free, live webcast must register by January 15, 2019.
‘Anyone who previously signed up to present at or attend the canceled December 5 hearing will have to register again.’
The FDA said the deadline to submit a public comment to docket FDA-2018-N-3952 had been extended through February 1, regardless of attendance at the public hearing.
Further information, including instructions for presenters, is included in the Federal Register notice.
Drug meeting rescheduled
